Osaic Holdings’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.82K | Buy |
6,810
+2,850
| +72% | +$2.44K | ﹤0.01% | 6044 |
|
2025
Q1 | $2.61K | Sell |
3,960
-2,670
| -40% | -$1.76K | ﹤0.01% | 6372 |
|
2024
Q4 | $6.76K | Buy |
6,630
+910
| +16% | +$928 | ﹤0.01% | 5947 |
|
2024
Q3 | $4.96K | Sell |
5,720
-200
| -3% | -$174 | ﹤0.01% | 6086 |
|
2024
Q2 | $2.13K | Sell |
5,920
-3,630
| -38% | -$1.3K | ﹤0.01% | 6415 |
|
2024
Q1 | $6.4K | Sell |
9,550
-394
| -4% | -$264 | ﹤0.01% | 5883 |
|
2023
Q4 | $5.4K | Sell |
9,944
-2,566
| -21% | -$1.39K | ﹤0.01% | 6062 |
|
2023
Q3 | $7.5K | Sell |
12,510
-4,190
| -25% | -$2.51K | ﹤0.01% | 6039 |
|
2023
Q2 | $22.1K | Sell |
16,700
-2,523
| -13% | -$3.34K | ﹤0.01% | 5480 |
|
2023
Q1 | $32.8K | Buy |
19,223
+331
| +2% | +$565 | ﹤0.01% | 5240 |
|
2022
Q4 | $60.4K | Sell |
18,892
-2,458
| -12% | -$7.86K | ﹤0.01% | 4788 |
|
2022
Q3 | $105K | Hold |
21,350
| – | – | ﹤0.01% | 4323 |
|
2022
Q2 | $89K | Sell |
21,350
-2,547
| -11% | -$10.6K | ﹤0.01% | 4515 |
|
2022
Q1 | $192K | Buy |
23,897
+2,684
| +13% | +$21.6K | ﹤0.01% | 4067 |
|
2021
Q4 | $160K | Sell |
21,213
-763
| -3% | -$5.76K | ﹤0.01% | 4162 |
|
2021
Q3 | $199K | Buy |
21,976
+1,664
| +8% | +$15.1K | ﹤0.01% | 3906 |
|
2021
Q2 | $244K | Sell |
20,312
-7,880
| -28% | -$94.7K | ﹤0.01% | 3700 |
|
2021
Q1 | $353K | Buy |
28,192
+11,572
| +70% | +$145K | ﹤0.01% | 3234 |
|
2020
Q4 | $257K | Sell |
16,620
-885
| -5% | -$13.7K | ﹤0.01% | 3245 |
|
2020
Q3 | $166K | Sell |
17,505
-322
| -2% | -$3.05K | ﹤0.01% | 3407 |
|
2020
Q2 | $161K | Sell |
17,827
-807
| -4% | -$7.29K | ﹤0.01% | 3327 |
|
2020
Q1 | $119K | Buy |
+18,634
| New | +$119K | ﹤0.01% | 3327 |
|